Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15726670 | 0.95 | CYP3A4 (0.35) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL2577691 | 0.90 | CYP3A4 (0.44) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL15726604 | 0.89 | KMT2A (0.44) | CYP3A4TSHRLMNATDP1KMT2A | |
| SCHEMBL15726608 | 0.88 | KMT2A (0.36) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL15726640 | 0.87 | KMT2A (0.38) | CYP3A4TSHRGAALMNAKMT2A | |
| SCHEMBL15708348 | 0.84 | CYP3A4 (0.42) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL34741 | 0.82 | CYP3A4 (0.47) | CYP3A4TSHRTDP1 | |
| SCHEMBL17083878 | 0.80 | KMT2A (0.37) | LMNATDP1KMT2AALDH1A1MAPT | |
| SCHEMBL25873139 | 0.80 | PRSS1 (0.49) | ALDH1A1HSD17B10 | |
| SCHEMBL16270236 | 0.80 | KMT2A (0.42) | GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160023998-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL LLC (US) | 2016-01-28 | — | — | US | disclosed |
| US-9174924-B2 | Hydrolysable linkers and cross-linkers for absorbable polymers | BEZWADA BIOMEDICAL, LLC (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150259275-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL LLC (US) | 2015-09-17 | — | — | US | disclosed |
| US-9045396-B2 | Hydrolysable linkers and cross-linkers for absorbable polymers | BEZWADA BIOMEDICAL, LLC (US) | 2015-06-02 | — | — | US | disclosed |
| US-20140163253-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL, LLC (US) | 2014-06-12 | — | — | US | disclosed |
| US-8664429-B2 | Hydrolysable linkers and cross-linkers for absorbable polymers | BEZWADA BIOMEDICAL, LLC (US) | 2014-03-04 | — | — | US | disclosed |
| US-20130310596-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL, LLC (US) | 2013-11-21 | — | — | US | disclosed |
| US-20120197037-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL, LLC (US) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259275-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | CYP3A4 1200/4885TSHR 4662/4885GAA 429/4885 |
| US-20120197037-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | CYP3A4 1200/4885TSHR 4662/4885GAA 429/4885 |
| US-20160023998-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | CYP3A4 1200/4885TSHR 4662/4885GAA 429/4885 |
| US-20130310596-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | CYP3A4 1200/4885TSHR 4662/4885GAA 429/4885 |
| US-20140163253-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | CYP3A4 1200/4885TSHR 4662/4885GAA 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.